SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-02-004489
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
11
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.txt 10-K 285015
3 CERTIFICATE OF AMENDMENT dex35.txt EX-3.5 2132
4 AMEND NO. 3 TO RESEARCH AND LICENSE AGREEMENT dex1041.txt EX-10.41 4573
5 CONSULTING AGREEMENT DATED 12/11/01 dex1042.txt EX-10.42 6693
6 INDEMNIFICATION AGREEMENT dex1045.txt EX-10.45 14722
7 SEVERANCE AGREEMENT (PAUL J. MELLETT) dex1046.txt EX-10.46 18464
8 SEVERANCE AGREEMENT (MARK SKALETSKY) dex1047.txt EX-10.47 19027
9 FIRST AMENDED AND RESTATED EXECUTIVE STOCK PURCHAS dex1048.txt EX-10.48 43882
10 FIRST AMENDED AND RESTATED EXECUTIVE STOCK PURCHAS dex1049.txt EX-10.49 40066
11 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 793
12 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.txt EX-23.1 973
  Complete submission text file 0001021408-02-004489.txt   439255
Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
ESSENTIAL THERAPEUTICS INC (Filer) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28006 | Film No.: 02594864
SIC: 2834 Pharmaceutical Preparations